A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine

PHASE3CompletedINTERVENTIONAL

Enrollment

763

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

September 30, 2002

Conditions

MigraineCommon MigraineClassic MigraineHeadache

Interventions

DRUG

topiramate

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236509 - A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine | Biotech Hunter | Biotech Hunter